From its initial price of $0.030 at presale stage 1, RXS has already leaped 485% to its present price of $0.175 in presale stage 11; projections suggest a possible 26x gain to $4.55 in the next 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback